Immunic, Inc. Current Assets
Immunic, Inc. (IMUX) had Current Assets of $157.83 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $157.83M.
- 2026-03-31: Assets, Current $188.76M.
- 2025-12-31: Assets, Current $22.87M.
- 2025-09-30: Assets, Current $39.27M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $157.83M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $188.76M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $22.87M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $39.27M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $59.84M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $18.98M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $39.33M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $63.27M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $84.98M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $102.61M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $52.53M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $65.23M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $86.55M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $106.58M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $125.86M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $86.65M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $104.76M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $115.88M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $104.99M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $122.50M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $101.69M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $120.28M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $133.75M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $137.54M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $53.02M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $23.60M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $32.23M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $34.52M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $39.49M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $9.99M 10-Q · filed 2019-04-10 | |
| 2018-12-31 | $13.33M 10-K · filed 2020-03-16 | $14.23M 10-K · filed 2019-03-04 |
| 2018-09-30 | $19.06M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $32.65M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $44.84M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $58.12M 10-K · filed 2019-03-04 | |
| 2017-09-30 | $67.96M 10-Q · filed 2017-10-25 | |
| 2017-06-30 | $78.06M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $88.30M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $61.46M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $69.46M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $75.44M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $79.24M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $85.09M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $62.61M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $75.45M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $90.62M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $104.82M 10-K · filed 2016-03-08 | |
| 2014-09-30 | $82.58M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $93.49M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $52.26M 10-Q · filed 2014-05-28 | |
| 2013-12-31 | $43.85M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |